Madrigal Pharmaceuticals EBIT 2010-2025 | MDGL

Madrigal Pharmaceuticals EBIT for the quarter ending March 31, 2025 was $-0.079B, a 47.83% decline year-over-year.

  • Madrigal Pharmaceuticals 2024 EBIT was -0.498B, a 30.85% increase from 2023.
  • Madrigal Pharmaceuticals 2023 EBIT was -0.38B, a 29.61% increase from 2022.
  • Madrigal Pharmaceuticals 2022 EBIT was -0.294B, a 21.07% increase from 2021.

EBIT can be defined as earnings before interest and taxes.

Madrigal Pharmaceuticals EBIT 2010-2025 | MDGL

  • Madrigal Pharmaceuticals 2024 EBIT was -0.498B, a 30.85% increase from 2023.
  • Madrigal Pharmaceuticals 2023 EBIT was -0.38B, a 29.61% increase from 2022.
  • Madrigal Pharmaceuticals 2022 EBIT was -0.294B, a 21.07% increase from 2021.

EBIT can be defined as earnings before interest and taxes.